Labour's AstraZeneca Snub Threatens UK Science Hub Ambitions
Labour's refusal to support AstraZeneca's £450 million Liverpool vaccine plant clashes with their science goals, contrasting with US government support and potentially driving investment away from the UK.
Labour's AstraZeneca Snub Threatens UK Science Hub Ambitions
Labour's refusal to support AstraZeneca's £450 million Liverpool vaccine plant clashes with their science goals, contrasting with US government support and potentially driving investment away from the UK.
Progress
64% Bias Score
Walgreens Suspends Dividend After 90+ Years, Stock Plunges 11%
Walgreens Boots Alliance Inc. suspended its dividend after more than 90 years, causing an 11% stock drop in premarket trading due to financial challenges including legal issues, rising costs, and reduced consumer spending; the company plans to close 1200 stores.
Walgreens Suspends Dividend After 90+ Years, Stock Plunges 11%
Walgreens Boots Alliance Inc. suspended its dividend after more than 90 years, causing an 11% stock drop in premarket trading due to financial challenges including legal issues, rising costs, and reduced consumer spending; the company plans to close 1200 stores.
Progress
40% Bias Score
Europe's Slow Progress Towards Pharmaceutical Sovereignty
Europe's pharmaceutical supply chain is vulnerable due to reliance on distant countries for raw materials and production; this has led to shortages of essential medicines, prompting calls for higher drug prices and increased domestic production.
Europe's Slow Progress Towards Pharmaceutical Sovereignty
Europe's pharmaceutical supply chain is vulnerable due to reliance on distant countries for raw materials and production; this has led to shortages of essential medicines, prompting calls for higher drug prices and increased domestic production.
Progress
40% Bias Score
Record Irish Tax Revenue: A Windfall Threatened by US Policies
Ireland's 2023 tax revenue hit a record \$108 billion, a 23% increase driven by Apple's \$11 billion tax payment and rising income tax. However, this prosperity is threatened by potential US tariffs and tax code changes.
Record Irish Tax Revenue: A Windfall Threatened by US Policies
Ireland's 2023 tax revenue hit a record \$108 billion, a 23% increase driven by Apple's \$11 billion tax payment and rising income tax. However, this prosperity is threatened by potential US tariffs and tax code changes.
Progress
48% Bias Score
FTC Accuses PBMs of \$8.7 Billion in Price Gouging
The FTC released a report accusing the three largest Pharmacy Benefit Managers (PBMs)—OptumRx, Express Scripts, and CVS Caremark—of marking up specialty generic drug prices by over \$7.3 billion from 2017-2022, and an additional \$1.4 billion through spread pricing, ultimately increasing patient cos...
FTC Accuses PBMs of \$8.7 Billion in Price Gouging
The FTC released a report accusing the three largest Pharmacy Benefit Managers (PBMs)—OptumRx, Express Scripts, and CVS Caremark—of marking up specialty generic drug prices by over \$7.3 billion from 2017-2022, and an additional \$1.4 billion through spread pricing, ultimately increasing patient cos...
Progress
24% Bias Score
Eli Lilly Stock Tumbles Despite Positive 2025 Outlook
Eli Lilly's stock fell over 7% on Tuesday after the company lowered its 2024 revenue outlook due to disappointing fourth-quarter sales of its GLP-1 weight-loss and diabetes drugs, Mounjaro and Zepbound, which missed estimates by a combined $500 million, despite resolving supply chain issues and main...
Eli Lilly Stock Tumbles Despite Positive 2025 Outlook
Eli Lilly's stock fell over 7% on Tuesday after the company lowered its 2024 revenue outlook due to disappointing fourth-quarter sales of its GLP-1 weight-loss and diabetes drugs, Mounjaro and Zepbound, which missed estimates by a combined $500 million, despite resolving supply chain issues and main...
Progress
40% Bias Score
US-EU Trade Conflict Threatens German Pharmaceutical Industry
A potential US-EU trade conflict under Donald Trump significantly threatens Germany's pharmaceutical industry, which exported \$26 billion worth of drugs to the US in 2023, making the US its most important export market and supplier of raw materials. This dependence raises concerns about potential d...
US-EU Trade Conflict Threatens German Pharmaceutical Industry
A potential US-EU trade conflict under Donald Trump significantly threatens Germany's pharmaceutical industry, which exported \$26 billion worth of drugs to the US in 2023, making the US its most important export market and supplier of raw materials. This dependence raises concerns about potential d...
Progress
44% Bias Score
Teva Exceeds 2024 Expectations but 2025 Outlook Disappoints
Teva Pharmaceutical Industries reported exceeding 2024 financial results with $4.2 billion in Q4 revenue and $16.5 billion in full-year revenue; however, its share price fell almost 10% due to a less optimistic 2025 outlook of $16.8-17.4 billion in revenue and $2.35-2.65 non-GAAP EPS.
Teva Exceeds 2024 Expectations but 2025 Outlook Disappoints
Teva Pharmaceutical Industries reported exceeding 2024 financial results with $4.2 billion in Q4 revenue and $16.5 billion in full-year revenue; however, its share price fell almost 10% due to a less optimistic 2025 outlook of $16.8-17.4 billion in revenue and $2.35-2.65 non-GAAP EPS.
Progress
36% Bias Score
Canadian Court Certifies Class-Action Lawsuit Against Opioid Companies
A British Columbia Supreme Court judge certified a class-action lawsuit against over 40 opioid companies for allegedly over-promoting prescription opioid use, leading to substantial public health care costs; the B.C. government, joined by all other Canadian governments, alleges wrongful conduct and ...
Canadian Court Certifies Class-Action Lawsuit Against Opioid Companies
A British Columbia Supreme Court judge certified a class-action lawsuit against over 40 opioid companies for allegedly over-promoting prescription opioid use, leading to substantial public health care costs; the B.C. government, joined by all other Canadian governments, alleges wrongful conduct and ...
Progress
44% Bias Score
Healthcare Sector Lags Despite Innovation, Poised for Growth
The healthcare sector, particularly biotech, is underperforming despite promising innovations due to investor apathy and post-pandemic market corrections; however, experts anticipate future growth fueled by technological advancements, demographic shifts, and potential deregulation.
Healthcare Sector Lags Despite Innovation, Poised for Growth
The healthcare sector, particularly biotech, is underperforming despite promising innovations due to investor apathy and post-pandemic market corrections; however, experts anticipate future growth fueled by technological advancements, demographic shifts, and potential deregulation.
Progress
56% Bias Score
Iran's Medicine Crisis: Price Hikes, Shortages, and Hospital Thefts
Due to reduced government subsidies, a rise in the dollar's exchange rate, and raw material shortages, medicine prices in Iran have sharply increased, causing shortages, hospital drug thefts, and endangering patients; the government's debt to the pharmaceutical industry and insurance companies furth...
Iran's Medicine Crisis: Price Hikes, Shortages, and Hospital Thefts
Due to reduced government subsidies, a rise in the dollar's exchange rate, and raw material shortages, medicine prices in Iran have sharply increased, causing shortages, hospital drug thefts, and endangering patients; the government's debt to the pharmaceutical industry and insurance companies furth...
Progress
40% Bias Score
Galapagos Restructures, Splits into Two, Cuts 300 Jobs
Galapagos, a Dutch-Belgian biotech firm facing financial struggles after setbacks in US market approvals, is splitting into two entities: one focusing on oncology cell therapy, and SpinCo, receiving \u20ac2.45 billion for acquisitions, resulting in 300 job cuts and separation from a restrictive agre...
Galapagos Restructures, Splits into Two, Cuts 300 Jobs
Galapagos, a Dutch-Belgian biotech firm facing financial struggles after setbacks in US market approvals, is splitting into two entities: one focusing on oncology cell therapy, and SpinCo, receiving \u20ac2.45 billion for acquisitions, resulting in 300 job cuts and separation from a restrictive agre...
Progress
40% Bias Score